The Use of Recombinant Activated FVII (rFVIIa, Novoseven) in the Treatment of a Lifethreatening Retroperitoneal Hemorrhage in a Hemophilia A Patient with Inhibitors to FVIII
Data(s) |
24/01/2013
24/01/2013
2000
|
---|---|
Identificador |
IN: 16th International Congress on Thrombosis, 2000, 5 a 8 Mai. Porto, Portugal |
Idioma(s) |
eng |
Publicador |
Serviço de Imuno-Hemoterapia do Hospital de S. José |
Direitos |
openAccess |
Palavras-Chave | #Factor VIII #Factor VIIa |
Tipo |
other |